Quotient Sciences has access to scale up and pilot plant assets that complement our on-site facilities, featuring a capacity range between 50 L and 1300 L capable of producing 5-100 kg in batch. Our internal manufacturing assets (batch, CSTR, trickle bed and plug flow) range from multigram to multikilogram capacity (multitonne p.a capability). Additionally, our investment in innovative, flexible modular manufacturing technology enables us to quickly configure reactors for drug substance (API) manufacturing, then rapidly reassemble reactors for the next project.
Quotient Sciences can meet drug substance requirements from preclinical through to full scale commercial phases. The scale up process is executed by a highly experienced manufacturing team, providing customers with a secure source of supply for technically challenging projects.
Sincerely Pharmaceutical Tech
Regards,
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling
